These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22366950)

  • 1. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
    Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
    Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
    Intlekofer AM; Takemoto N; Kao C; Banerjee A; Schambach F; Northrop JK; Shen H; Wherry EJ; Reiner SL
    J Exp Med; 2007 Sep; 204(9):2015-21. PubMed ID: 17698591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T cell help prevents CD8 T cell exhaustion and promotes control of Mycobacterium tuberculosis infection.
    Lu YJ; Barreira-Silva P; Boyce S; Powers J; Cavallo K; Behar SM
    Cell Rep; 2021 Sep; 36(11):109696. PubMed ID: 34525366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.
    Cerboni C; Ardolino M; Santoni A; Zingoni A
    Blood; 2009 Mar; 113(13):2955-64. PubMed ID: 19124832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
    Rajasekaran K; Xiong V; Fong L; Gorski J; Malarkannan S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells.
    Fernández-Sánchez A; Baragaño Raneros A; Carvajal Palao R; Sanz AB; Ortiz A; Ortega F; Suárez-Álvarez B; López-Larrea C
    Epigenetics; 2013 Jan; 8(1):66-78. PubMed ID: 23235109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
    Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
    Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.
    Legroux L; Moratalla AC; Laurent C; Deblois G; Verstraeten SL; Arbour N
    Front Immunol; 2019; 10():154. PubMed ID: 30787931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D stimulation of CD8
    Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
    Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
    Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
    J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.
    Jensen H; Folkersen L; Skov S
    PLoS One; 2012; 7(8):e41577. PubMed ID: 22870231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells are primed by ANRS MVA(HIV)-infected DCs, via a mechanism involving NKG2D and membrane-bound IL-15, to control HIV-1 infection in CD4+ T cells.
    Moreno-Nieves UY; Didier C; Lévy Y; Barré-Sinoussi F; Scott-Algara D;
    Eur J Immunol; 2014 Aug; 44(8):2370-9. PubMed ID: 24777763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.
    Richard J; Sindhu S; Pham TN; Belzile JP; Cohen EA
    Blood; 2010 Feb; 115(7):1354-63. PubMed ID: 20008788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D signaling certifies effector CD8 T cells for memory formation.
    Perez C; Prajapati K; Burke B; Plaza-Rojas L; Zeleznik-Le NJ; Guevara-Patino JA
    J Immunother Cancer; 2019 Feb; 7(1):48. PubMed ID: 30777125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
    Denkers EY; Scharton-Kersten T; Barbieri S; Caspar P; Sher A
    J Exp Med; 1996 Jul; 184(1):131-9. PubMed ID: 8691126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART.
    Giuliani E; Vassena L; Desimio MG; Buonomini AR; Malagnino V; Andreoni M; Doria M
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):347-56. PubMed ID: 26509932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
    André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A
    Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.
    Lhomme E; Richert L; Moodie Z; Pasin C; Kalams SA; Morgan C; Self S; De Rosa SC; Thiébaut R
    PLoS One; 2016; 11(4):e0152952. PubMed ID: 27124598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.